Astrana Health Inc. - Common Stock (ASTH)

35.65
+1.52 (4.44%)
NASDAQ· Last Trade: Aug 7th, 11:32 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close34.13
Open34.54
Bid35.51
Ask35.80
Day's Range34.48 - 36.61
52 Week Range18.08 - 51.60
Volume257,517
Market Cap1.97B
PE Ratio (TTM)178.22
EPS (TTM)0.2
Dividend & YieldN/A (N/A)
1 Month Average Volume548,399

Chart

About Astrana Health Inc. - Common Stock (ASTH)

Astrana Health Inc. is a public company focused on the advancement of healthcare solutions aimed at improving patient outcomes and enhancing the overall quality of care. The company develops innovative products and services that leverage technology to address various health challenges, including chronic diseases and mental health conditions. By integrating research and development with clinical expertise, Astrana Health strives to create effective treatment options and support systems that empower both patients and healthcare providers. Their commitment to innovation and patient-centered care positions them as a formidable player in the evolving healthcare landscape. Read More

News & Press Releases

ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook
Healthcare services company Astrana Health missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million. Next ...
Via StockStory · August 7, 2026
Astrana Health Q2 Earnings Call Highlightsmarketbeat.com
Astrana Health (NASDAQ:ASTH) reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share reached a record $0.80, up 45% year over year, as the company cited growth in value-based care arrang
Via MarketBeat · August 6, 2026
Astrana Health (NASDAQ:ASTH) Falls on Q2 Revenue Miss Despite Earnings Beatchartmill.com
Via Chartmill · August 6, 2026
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1%
Healthcare services company Astrana Health fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million....
Via StockStory · August 6, 2026
Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentumchartmill.com
Via Chartmill · July 3, 2026
Astrana Health (NASDAQ:ASTH) Post-Earnings Slide: Revenue Beat Fails to Offset EPS Misschartmill.com
Via Chartmill · May 7, 2026
Astrana Health (ASTH) Q2 Earnings: What To Expect
Healthcare services company Astrana Health will be reporting results this Thursday after market hours. Here’s what to look for. Astrana Health beat analysts’...
Via StockStory · August 4, 2026
2 Reasons to Like ASTH and 1 to Stay Skeptical
The past six months have been a windfall for Astrana Health’s shareholders. The company’s stock price has jumped 79%, hitting $49.01 per share. This was part...
Via StockStory · July 15, 2026
1 Profitable Stock to Target This Week and 2 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · July 10, 2026
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via StockStory · June 30, 2026
2 Russell 2000 Stocks with Exciting Potential and 1 We Ignore
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via StockStory · June 15, 2026
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...
Via StockStory · June 5, 2026
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Via StockStory · May 25, 2026
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Via StockStory · May 21, 2026
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via StockStory · May 19, 2026
2 Mooning Stocks Worth Investigating and 1 We Question
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...
Via StockStory · May 15, 2026
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call
Astrana Health’s first quarter was marked by progress in platform integration and the expansion of its AI-driven care model, leading to strong revenue growth...
Via StockStory · May 14, 2026
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectationsmarketbeat.com
Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue. Speaking at a Bank of America healthc
Via MarketBeat · May 12, 2026
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Via StockStory · May 11, 2026
Astrana Health (ASTH) Q1 2026 Earnings Transcriptfool.com
Astrana Health (ASTH) Q1 2026 Earnings Transcript
Via The Motley Fool · May 8, 2026
ASTH Q1 Deep Dive: AI-Enabled Platform, Full-Risk Expansion, and Operating Leverage Shape Results
Healthcare services company Astrana Health reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 55.6% year on year to $965.1 mill...
Via StockStory · May 8, 2026
Astrana Health (NASDAQ:ASTH) Beats Q1 CY2026 Sales Expectations
Healthcare services company Astrana Health reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 55.6% year on year to $965.1 m...
Via StockStory · May 7, 2026
Astrana Health (ASTH) Q1 Earnings Report Preview: What To Look For
Healthcare services company Astrana Health will be reporting results this Thursday afternoon. Here’s what to look for. Astrana Health beat analysts’ revenue ...
Via StockStory · May 5, 2026
2 Profitable Stocks on Our Watchlist and 1 Facing Headwinds
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via StockStory · May 4, 2026
1 Healthcare Stock to Target This Week and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...
Via StockStory · April 22, 2026